XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Consolidated Balance Sheets    
Cash and due from banks, including reserve requirements of $0 at both 3/31/23 and 12/31/22 $ 40,100 $ 50,061
Interest-bearing deposits 42,921 21,535
Cash and cash equivalents 83,021 71,596
Investment securities available for sale 399,148 445,394
Other investments 2,628 2,656
Total securities 401,776 448,050
Mortgage loans held for sale 417 211
Loans 1,050,871 1,032,608
Less allowance for credit losses (9,617) (10,494)
Net loans 1,041,254 1,022,114
Premises and equipment, net 18,194 18,205
Cash surrender value of life insurance 17,806 17,703
Right of use lease asset 4,949 5,116
Accrued interest receivable and other assets 35,275 37,932
Total assets 1,602,692 1,620,927
Deposits:    
Noninterest-bearing demand 502,702 523,088
Interest-bearing demand, MMDA & savings 742,473 814,128
Time, over $250,000 67,595 31,001
Other time 100,671 66,998
Total deposits 1,413,441 1,435,215
Securities sold under agreements to repurchase 39,535 47,688
Junior subordinated debentures 15,464 15,464
Lease liability 5,033 5,185
Accrued interest payable and other liabilities 14,436 12,180
Total liabilities 1,487,909 1,515,732
Shareholders' equity:    
Preferred stock, no par value; authorized 5,000,000 shares; no shares issued and outstanding 0 0
Common stock, no par value; authorized 20,000,000 shares; issued and outstanding 5,637,021 shares at March 31, 2023 and 5,636,830 shares at December 31, 2022 52,642 52,636
Common stock held by deferred compensation trust, at cost; 158,356 shares at March 31, 2023 and 163,883 shares at December 31, 2022 (1,837) (2,181)
Deferred compensation 1,837 2,181
Retained earnings 100,565 100,156
Accumulated other comprehensive loss (38,424) (47,597)
Total shareholders' equity 114,783 105,195
Total liabilities and shareholders' equity $ 1,602,692 $ 1,620,927